The increasing prevalence of cardiovascular diseases and disorders worldwide is driving the growth of the implantable pacemaker market. Technological advancements in pacemaker devices, such as miniaturization and wireless connectivity, are also fueling market growth. Additionally, the growing elderly population and rising awareness about the benefits of pacemakers are contributing to the market expansion.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Boston Scientific, Zoll Medical, Medtronic, BIOTRONIK, MicroPort Scientific, Cook, MEDICO SpA, Pacetronix, Abbott, Osypka Medical |
The stringent regulatory requirements for the approval of pacemaker devices are acting as a major restraint for market growth. The high cost associated with pacemaker implantation and maintenance is also hindering market growth. These factors are limiting the adoption of pacemakers, particularly in developing countries where healthcare infrastructure is less advanced.